Frontiers in Immunology (Jun 2022)

Role of NLRP3 Inflammasome in Rheumatoid Arthritis

  • Hui Yin,
  • Hui Yin,
  • Na Liu,
  • Na Liu,
  • Keshav Raj Sigdel,
  • Lihua Duan,
  • Lihua Duan

DOI
https://doi.org/10.3389/fimmu.2022.931690
Journal volume & issue
Vol. 13

Abstract

Read online

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by multi-articular, symmetrical and invasive arthritis resulting from immune system abnormalities involving T and B lymphocytes. Although significant progress has been made in the understanding of RA pathogenesis, the underlying mechanisms are not fully understood. Recent studies suggest that NLRP3 inflammasome, a regulator of inflammation, might play an important role in the development of RA. There have been increasing clinical and pre-clinical evidence showing the treatment of NLRP3/IL-1β in inflammatory diseases. To provide a foundation for the development of therapeutic strategies, we will briefly summarize the roles of NLRP3 inflammasome in RA and explore its potential clinical treatment.

Keywords